Tags

Type your tag names separated by a space and hit enter

The metabolic syndrome is associated with reduced risk of prostate cancer.
Am J Epidemiol 2006; 164(11):1094-102AJ

Abstract

Diabetes is associated with reduced risk of prostate cancer, but whether the metabolic syndrome is associated with prostate cancer is not established. The authors assessed this association in the Atherosclerosis Risk in Communities (ARIC) Study, comprising 6,429 men in four US communities initially with no history of cancer and aged 45-64 years. Metabolic syndrome and other risk factors were assessed in 1987-1989. Follow-up for prostate cancer incidence (n = 385 through 2000) was accomplished through cancer registry and hospital linkage. At baseline, 1,871 men (29.5%) had the metabolic syndrome. After the authors adjusted for other risk factors, men with the metabolic syndrome (> or =3 components) were significantly less likely to develop prostate cancer (relative risk = 0.77, 95% confidence interval: 0.60, 0.98) than men without the metabolic syndrome. Diabetes was negatively associated with prostate cancer, although the confidence interval included 1 (relative risk = 0.73, 95% confidence interval: 0.51, 1.05). When diabetic participants were excluded, the inverse association between metabolic syndrome and prostate cancer incidence was slightly strengthened. In this study, the metabolic syndrome was associated with decreased prostate cancer incidence. The authors hypothesize that this finding reflects a decrease in bioavailable (free and albumin-bound) testosterone with the metabolic syndrome and a concomitant reduction in prostate cancer risk.

Authors+Show Affiliations

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16968859

Citation

Tande, Aaron J., et al. "The Metabolic Syndrome Is Associated With Reduced Risk of Prostate Cancer." American Journal of Epidemiology, vol. 164, no. 11, 2006, pp. 1094-102.
Tande AJ, Platz EA, Folsom AR. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol. 2006;164(11):1094-102.
Tande, A. J., Platz, E. A., & Folsom, A. R. (2006). The metabolic syndrome is associated with reduced risk of prostate cancer. American Journal of Epidemiology, 164(11), pp. 1094-102.
Tande AJ, Platz EA, Folsom AR. The Metabolic Syndrome Is Associated With Reduced Risk of Prostate Cancer. Am J Epidemiol. 2006 Dec 1;164(11):1094-102. PubMed PMID: 16968859.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The metabolic syndrome is associated with reduced risk of prostate cancer. AU - Tande,Aaron J, AU - Platz,Elizabeth A, AU - Folsom,Aaron R, Y1 - 2006/09/12/ PY - 2006/9/14/pubmed PY - 2007/1/31/medline PY - 2006/9/14/entrez SP - 1094 EP - 102 JF - American journal of epidemiology JO - Am. J. Epidemiol. VL - 164 IS - 11 N2 - Diabetes is associated with reduced risk of prostate cancer, but whether the metabolic syndrome is associated with prostate cancer is not established. The authors assessed this association in the Atherosclerosis Risk in Communities (ARIC) Study, comprising 6,429 men in four US communities initially with no history of cancer and aged 45-64 years. Metabolic syndrome and other risk factors were assessed in 1987-1989. Follow-up for prostate cancer incidence (n = 385 through 2000) was accomplished through cancer registry and hospital linkage. At baseline, 1,871 men (29.5%) had the metabolic syndrome. After the authors adjusted for other risk factors, men with the metabolic syndrome (> or =3 components) were significantly less likely to develop prostate cancer (relative risk = 0.77, 95% confidence interval: 0.60, 0.98) than men without the metabolic syndrome. Diabetes was negatively associated with prostate cancer, although the confidence interval included 1 (relative risk = 0.73, 95% confidence interval: 0.51, 1.05). When diabetic participants were excluded, the inverse association between metabolic syndrome and prostate cancer incidence was slightly strengthened. In this study, the metabolic syndrome was associated with decreased prostate cancer incidence. The authors hypothesize that this finding reflects a decrease in bioavailable (free and albumin-bound) testosterone with the metabolic syndrome and a concomitant reduction in prostate cancer risk. SN - 0002-9262 UR - https://www.unboundmedicine.com/medline/citation/16968859/The_metabolic_syndrome_is_associated_with_reduced_risk_of_prostate_cancer_ L2 - https://academic.oup.com/aje/article-lookup/doi/10.1093/aje/kwj320 DB - PRIME DP - Unbound Medicine ER -